|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||||
|
|||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s8B7A2222-3846-11EF-A668-E18C85CE164B&I=39IZM&T=&OP=Display&O=html&O1=12670495&O2=954925529885&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DThe%2520BET%2520bromodomain%2520inhibitor%2520CPI203%2520improves%2520lenalidomide%2520and%2520dexamethasone%2520activity%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520of%2520multiple%2520myeloma%2520by%2520blockade%2520of%2520Ikaros%2520and%2520MYC%2520signaling%26rft.au%3DD%25C3%25ADaz%252C%2520Tania%26rft.au%3DLozano%252C%2520Ester%26rft.au%3DMena%252C%2520Mari-Pau%26rft.au%3DRodr%25C3%25ADguez%252C%2520Vanina%26rft.date%3D2017-10-01%26rft.eissn%3D1592-8721%26rft.epage%3D1784%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issue%3D10%26rft.jtitle%3DHaematologica%2520%2528Roma%2529%26rft.spage%3D1776%26rft.volume%3D102%26rft_id%3Dinfo%253Adoi%252F10.3324%252Fhaematol.2017.164632%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,3-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,4-ROAD_DIRECTORY_OF_OPEN_ACCESS_SCHOLARLY_RESOURCES-getFullTxt-object,5-COBIB_SI_LCL-getHolding-object,6-DOI-getDOI-object,7-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,8-NCBI_PUBMED_FREE-getAbstract-object,9-ISI_WEB_OF_SCIENCE-getAuthor-object,10-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,11-REFWORKS_EXPORT_TOOL-getReference-object,12-SHERPA_RoMEO_LCL-getWebService-object,13-GOOGLE_SCHOLAR_FREE-getWebSearch-object,14-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.314659&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12670495-s8B7A2222-3846-11EF-A668-E18C85CE164B" timestamp="2024-07-02T09:41:53Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925529885</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity inin vitroandin vivomodels of multiple myeloma by blockade of Ikaros and MYC signaling</jnl:atitle>
<jnl:jtitle>Haematologica</jnl:jtitle>
<jnl:date>2017-10-30</jnl:date>
<jnl:spage>1776</jnl:spage>
<jnl:epage>1784</jnl:epage>
<jnl:coden>HAEMAX</jnl:coden>
<jnl:issn>0390-6078</jnl:issn>
<jnl:volume>102</jnl:volume>
<jnl:issue>10</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1592-8721</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>HAEMAX</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:b7d391c15af07b5f032892f9d6eb23f711fecec2</ctx:identifier>
<ctx:identifier>urn:UUID:s8B7A2222-3846-11EF-A668-E18C85CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)